DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

11 API Suppliers, 6 USDMF, 3 CEP/COS, 2 JDMF, 6 KDMF, 1 NDC API, 2 Listed Suppliers, $ API Reference Price

11 API Suppliers
6 USDMF
3 CEP/COS
2 JDMF
6 KDMF
1 NDC API
2 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

26 Drugs in Development

26 Drugs in Development

FINISHED DOSAGE FORMULATIONS

6 FDF Dossiers, 5 FDA Orange Book, 1 South Africa

6 FDF Dossiers
5 FDA Orange Book
1 South Africa

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 8 Actylis, 1 BASF, 1 Finar, 4 Gangwal Chemicals, 1 Kerry, 1 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pluviaendo, 6 Seppic

relatedExcipients
1 Nanjing Well Pharmaceutical
1 Pfanstiehl
8 Actylis
1 BASF
1 Finar
4 Gangwal Chemicals
1 Kerry
1 Microlex e.U
1 Nanjing Bold Chemical
1 Pluviaendo
6 Seppic

EXCIPIENTS BY APPLICATIONS

14 Parenteral, 10 Solubilizers, 4 Topical, 3 Film Formers & Plasticizers, 3 Emulsifying Agents, 2 Surfactant & Foaming Agents, 2 Thickeners and Stabilizers, 1 Controlled & Modified Release, 1 Direct Compression, 1 Co-Processed Excipients, 1 Rheology Modifiers, 1 Fillers, Diluents & Binders, 1 Coating Systems & Additives, 1 Taste Masking, 1 API Stability Enhancers

excipientsByApplications
14 Parenteral
10 Solubilizers
4 Topical
3 Film Formers & Plasticizers
3 Emulsifying Agents
2 Surfactant & Foaming Agents
2 Thickeners and Stabilizers
1 Controlled & Modified Release
1 Direct Compression
1 Co-Processed Excipients
1 Rheology Modifiers
1 Fillers, Diluents & Binders
1 Coating Systems & Additives
1 Taste Masking
1 API Stability Enhancers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 28 NEWS #PharmaBuzz

media
1 DATA COMPILATION #PharmaFlow
28 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 Annual Reports

globalSalesInformation
3 Annual Reports

MARKET PLACE

9 APIs, 3 FDF Dossiers

marketPlace
9 APIs
3 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM

otherSolutions
2 EDQM

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 428

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

26DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

2,474

Finished Drug Prices

26 RELATED EXCIPIENT COMPANIES

46EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 88755-39-9, Chembl2000337, Runx1/eto tetramerization-in-1, Nsc162496, Schembl16211954, Dtxsid40864143

Molecular Formula

C₁₈H₁₄O₇

Molecular Weight

342.3 g/mol

InChI Key

PPEBBOHQEAQKSW-UHFFFAOYSA-N

1 2D Structure

Hyaluronidase

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2,4-bis(1,3-benzodioxol-5-yl)-4-oxobutanoic acid

2.1.2 InChI

InChI=1S/C18H14O7/c19-13(11-2-4-15-17(6-11)25-9-23-15)7-12(18(20)21)10-1-3-14-16(5-10)24-8-22-14/h1-6,12H,7-9H2,(H,20,21)

2.1.3 InChI Key

PPEBBOHQEAQKSW-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1OC2=C(O1)C=C(C=C2)C(CC(=O)C3=CC4=C(C=C3)OCO4)C(=O)O

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 88755-39-9

2. Chembl2000337

3. Runx1/eto Tetramerization-in-1

4. Nsc162496

5. Schembl16211954

6. Dtxsid40864143

7. Bdbm50392853

8. 2,3]dioxol-5-yl)-4-oxobutanoic Acid

9. Nsc-162496

10. Hy-151411

11. Cs-0611487

12. Ft-0627100

13. A937131

14. Butanoic Acid,4-bis[1,3-benzodioxol-5-yl]-4-oxo-

15. 2,4-bis(2h-1,3-benzodioxol-5-yl)-4-oxobutanoic Acid

2.3 Create Date

2005-03-26

3 Chemical and Physical Properties

Molecular Formula	C₁₈H₁₄O₇
Molecular Weight	342.3 g/mol
XLogP3	2.4
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	5
Exact Mass	342.07395278 g/mol
Monoisotopic Mass	342.07395278 g/mol
Topological Polar Surface Area	91.3 Å²
Heavy Atom Count	25
Formal Charge	0
Complexity	522
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

API SUPPLIERS

01

SIGMA TAU

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CPHI Middle east

Not Confirmed

Not Confirmed

07

BBI Solutions

United Kingdom

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CPHI Middle east

Not Confirmed

Only 10 entries up to this point, click to access all

U.S.A

DDL Conference

Not Confirmed

06

Worthington Biochem Corp

U.S.A

DDL Conference

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

01

BMI Korea

South Korea

DDL Conference

Not Confirmed

02

Humedix

South Korea

DDL Conference

Not Confirmed

03

Humedix

South Korea

DDL Conference

Not Confirmed

04

Ningbo Linzyme Biosciences

China

DDL Conference

Not Confirmed

05

Ningbo Linzyme Biosciences

China

DDL Conference

Not Confirmed

06

DDL Conference

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

01

Bioindustria L.I.M. Spa

Italy

CPHI Middle east

Not Confirmed

02

Sichuan Deebio Pharmaceutical Co., ...

China

CPHI Middle east

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

01 Argenx

Netherlands

CPHI Middle east

Not Confirmed

02 Argenx

Netherlands

CPHI Middle east

Not Confirmed

03 Johnson & Johnson

U.S.A

U.S.A

CPHI Middle east

Not Confirmed

10 Takeda Pharmaceutical

Japan

CPHI Middle east

Not Confirmed

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

South Africa

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Parenteral

01

Nanjing Well Pharmaceutical

China

Medlab Asia & Asia Health

Not Confirmed

Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet

Grade : Parenteral, Oral, Topical

Category : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical

Brand Name : Polysorbate 80

Application : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical

Excipient Details : Polysorbate 80 is used as a plasticizer, solubilizer, emulsifier, surfactant, and suspension stabilizer. It is also used in parenteral products.

Pharmacopoeia Ref : ChP/USP/EP/JP

Technical Specs : NA

Ingredient(s) : Polysorbate 80

02

Pfanstiehl

U.S.A

Medlab Asia & Asia Health

Not Confirmed

Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

Dosage Form : Injectable / Parenteral

Grade : Parenteral

Category : Parenteral

Brand Name : L-Histidine

Application : Parenteral

Excipient Details : Histidine is used in biotherapeutic formulations and protects monoclonal antibodies in both the liquid and lyophilized state.

Pharmacopoeia Ref : USP, EP, BP, JP, ChP

Technical Specs : pH 7.4

Ingredient(s) : L-Histidine Excipient

Excipients Web Link

U.S.A

Medlab Asia & Asia Health

Not Confirmed

Only 10 entries up to this point, click to access all

Solubilizers

Topical

Film Formers & Plasticizers

Emulsifying Agents

Surfactant & Foaming Agents

Thickeners and Stabilizers

Controlled & Modified Release

Direct Compression

Co-Processed Excipients

Rheology Modifiers

Fillers, Diluents & Binders

Coating Systems & Additives

Taste Masking

API Stability Enhancers

Digital Content

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

NEWS #PharmaBuzz

Global Sales Information

Do you need Business Intel? Ask us

Annual Reports

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

APIs

Hyaluronidase API needed in Canada [ENA11295]

Meshayu Consultants, an Indian company that provides consultancy services to healthcare sectors is looking for suppliers of Hyaluronidase API for commercial purpose. Interested suppliers can contact them via their email: hiren.trecspharma@gmail.com.

04 Sep 2021

Hyaluronidase (MOQ) API needed in India [ENA11044]

A company that deals in manufacturing and exporting of active pharmaceutical ingredients and bulk intermediates is looking for suppliers of Hyaluronidase (MOQ) API for development purpose.

05 Aug 2021

Hyaluronidase (2 kg) API needed in Brazil [ENA05976]

A leading company in the distribution of inputs for the pharmaceutical market, cosmetic and food industry is looking for suppliers of Hyaluronidase (2 kg) API.

07 Dec 2019

Hyaluronidase API needed in Korea [ENA05137]

A leading CDMO-centric pharmaceutical company in Korea dedicated to the globalization of the Korean pharmaceutical industry and the development of quality pharmaceutical products is looking for suppliers of Hyaluronidase API. Suppliers must support this enquiry with GMP and DMF.

11 Sep 2019

Hyaluronidase API (1 MT) needed China [ENA04252]

A company has many years of experience in the R&D and production capacity of adhesive materials is looking for suppliers of Hyaluronidase API (1 MT).

22 May 2019

CEP grade Hyaluronidase API needed in Korea [ENA02783]

MEDETT Global Co. Ltd., a Korean pharma company is looking for suppliers of CEP grade Hyaluronidase API. Interested suppliers can contact H.J. Kim via Tel: +82-10-5091-6489 or Email: sokim2007@daum.net.

29 Nov 2018

Hyaluronidase API (MOQ) needed in Russia [ENA02439]

One of the leading company in the Russian pharmaceutical market is looking for suppliers of Hyaluronidase API (MOQ) for domestic consumption.

26 Oct 2018

Hyaluronidase API (1kg) needed in Korea [ENA02039]

A manufacturer of high quality finished products based in Korea is looking for suppliers of Hyaluronidase API (1kg). Interested suppliers must support this enquiry with Certificate of Analysis (COA).

22 Sep 2018

Enquiry// Hyaluronidase API needed in Taiwan [ENA01818]

A leading and dynamic pharmaceutical organisation is looking for suppliers of Hyaluronidase API. Interested suppliers must support this enquiry with the following specifications: 1. Certificate of Analysis (COA) 2. Quotation of Hyaluronidase per 1kg in US Dollar 3. cGMP of your Hyaluronidase product.

07 Sep 2018

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF DOSSIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

EDQM

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Find Hyaluronidase manufacturers, exporters & distributors on PharmaCompass

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

11 API Suppliers

6 USDMF

3 CEP/COS

2 JDMF

6 KDMF

1 NDC API

2 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

26 Drugs in Development

FINISHED DOSAGE FORMULATIONS

6 FDF Dossiers

5 FDA Orange Book

1 South Africa

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical

1 Pfanstiehl

8 Actylis

1 BASF

1 Finar

4 Gangwal Chemicals

1 Kerry

1 Microlex e.U

1 Nanjing Bold Chemical

1 Pluviaendo

6 Seppic

EXCIPIENTS BY APPLICATIONS

14 Parenteral

10 Solubilizers

4 Topical

3 Film Formers & Plasticizers

3 Emulsifying Agents

2 Surfactant & Foaming Agents

2 Thickeners and Stabilizers

1 Controlled & Modified Release

1 Direct Compression

1 Co-Processed Excipients

1 Rheology Modifiers

1 Fillers, Diluents & Binders

1 Coating Systems & Additives

1 Taste Masking

1 API Stability Enhancers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

28 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 Annual Reports

MARKET PLACE

9 APIs

3 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 428

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

46EXCIPIENTS BY APPLICATIONS

01

02

03

04

05

06

07

08

09

10